Dernières nouvelles pour Summit Therapeutics (NASDAQ:SMMT) Stock

SUMMIT THERAPEUTICS INC

Summit Therapeutics

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Summit Therapeutics Inc

Billionaire entrepreneur Mark Cuban says he doesn't need a political title to shake up big systems—and if he were ever asked to replace Elon Musk in running the government, he'd still aim to shrink it dramatically.
<h2 class="wp-block-heading">Cuban Would Still Shrink Government—Just With a Plan</h2>
&#8220;Trying to cut the size of government&#8230; and cutting a lot of people for better or worse, comes with the territory,&#8221; Cuban said on a recent <a href="https://www.youtube.com/watch?v=di3AqpoLI74">episode</a> of &#8220;The Lincoln Project Podcast.&#8221; &#8220;You can&#8217;t make government smaller and not cut hundreds of thousands, if not, you know, some significant number.&#8221;
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li><a href="https://www.benzinga.com/money/startengine-own">The $1.3 billion startup investment boom: How this company's explosive growth is opening doors for everyday investors with a new $500 minimum</a></li>
</ul>
Cuban joined host Rick Wilson for a wide-ranging discussion about politics, tech culture, healthcare, and economic policy. Throughout the interview, Cuban stressed the importance of planning and transparency, and his belief that without a strategy, drastic government cuts result in more harm than good.
&#8220;Shock and awe is great, but if there&#8217;s no plan behind shock and awe, it&#8217;s just shock and awful,&#8221; he said.
Cuban recently slammed changes to Social Security as a <a href="https://www.benzinga.com/news/25/03/44498325/gonna-be-some-upset-seniors-at-town-halls-says-mark-cuban-he-calls-doge-social-security-actions-a-back-door-move-to-cut-payments">stealthy way to reduce benefits</a>. "Got to give Doge credit for being the first to cut entitlements," Cuban <a href="https://x.com/mcuban/status/1902418507901628602">posted</a> March 19 on X, referring to the Department of Government Efficiency, led by Musk. "End telephone support for Social Security, cut dozens of SS offices and make Grandma and Grandpa finally get online to confirm their payments. What an amazing back-door way to cut payments!"
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Got to give Doge credit for being the first to cut entitlements. End telephone support for Social Security, cut dozens of SS offices and make Grandma and Grandpa finally get online to confirm their payments. What an amazing back door way to cut payments! Gonna be some upset…
&mdash; Mark Cuban (@mcuban) <a href="https://twitter.com/mcuban/status/1902418507901628602?ref_src=twsrc%5Etfw">March 19, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He added, "Gonna be some upset seniors at town halls!" The post quickly went viral, with more than 9 million views.
Trending: <a href="https://www.benzinga.com/money/vatom-adv">Invest in the Future of Digital Engagement. Own a Piece of the $100 Billion Metaverse Today for Just $500.</a>
<h2 class="wp-block-heading">Government Cuts: Not If, But How</h2>
Cuban said he agreed with the idea of making government smaller, something he says he discussed with then-presidential candidate Kamala Harris while campaigning for her. But he disagrees with how it&#8217;s being done by current political leaders.
&#8220;What they&#8217;ve done is ready, fire, aim,&#8221; he said. According to him, there&#8217;s a right way to do it, with a staggered plan that communicates what you&#8217;re doing, &#8220;so there&#8217;s not chaos and economic uncertainty.&#8221;
He warned that slashing government jobs and funding without a plan can result in severe second-order effects, especially in small towns. &#8220;They&#8217;re cutting the forestry service and a lot of those people live in small towns in the state of Washington or the state of Oregon, and now all of a sudden, those towns, their economies are decimated.&#8221;
He also pointed out that <a href="https://www.benzinga.com/news/25/02/43853560/we-are-not-waste-education-researchers-slam-elon-musks-881-million-cuts-that-shut-down-studies-on-student-learning-and-school-data">cutting college grants and research budgets</a> leads to layoffs, impacting contractors, communities and the economy at large.
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
<h2 class="wp-block-heading">Not a Politician, but Still Speaking Out</h2>
Cuban made it known that he&#8217;s not running for office. But as a self-made billionaire, he said he&#8217;s in a unique position to <a href="https://www.benzinga.com/25/03/44431190/billionaire-mark-cuban-questions-motives-behind-national-turnaround-efforts-asks-who-will-be-worse-off-in-the-us-economic-shift">call things like he sees them</a> without worrying about political fallout.
&#8220;I got rich as f&#x2A;&#x2A;&#x2A;, so I didn't have to care what anybody thought,&#8221; Cuban said. &#8220;I'm focused on doing something I think is very beneficial, which is Cost Plus Drugs and <a href="https://www.benzinga.com/personal-finance/24/12/42742855/mark-cuban-says-this-is-single-payer-how-his-healthcare-model-could-transform-the-u-s-healthcare-system">changing health care and trying to save lives and save money</a>.&#8221;
Unlike many political donors, Cuban said he doesn't give money to candidates. Instead, he wants his ideas to stand on their own: &#8220;Either my ideas hold up and you think there&#8217;s value in them or they don&#8217;t. And if they don&#8217;t, that&#8217;s fine too.&#8221;
Read Next:
<ul>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.55 per share now</a>.</li>
<li>This platform is reshaping how you invest in private companies —<a href="https://www.benzinga.com/money/kingscrowd-adv"> and you can be a part of it for $0.18 per share</a></li>
</ul>

News

Mark Cuban Says, If They Replaced Elon Musk With Him, He's Still Try to Make Government Smaller By 'Cutting A Lot Of People'

McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) has outperformed the market over the past 10 years by 2.04% on an annualized basis producing an average annual return of 12.48%. Currently, McDonald's has a market capitalization of $222.91 billion. 
Buying $100 In MCD: If an investor had bought $100 of MCD stock 10 years ago, it would be worth $324.44 today based on a price of $312.00 for MCD at the time of writing.
<h3>McDonald's's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743464713_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) has outperformed the market over the past 5 years by 3.06% on an annualized basis producing an average annual return of 20.7%. Currently, Fiserv has a market capitalization of $123.95 billion. 
Buying $1000 In FI: If an investor had bought $1000 of FI stock 5 years ago, it would be worth $2,488.23 today based on a price of $220.83 for FI at the time of writing.
<h3>Fiserv's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743463809_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Fiserv Stock In The Last 5 Years

President <a href="https://www.benzinga.com/topic/trump">Donald Trump </a>appointed journalist Sara Carter as the next director of the Office of National Drug Control Policy (ONDCP), or the &#8220;drug czar,&#8221; <a href="https://www.foxnews.com/politics/trump-appoints-sara-carter-next-drug-czar-says-she-will-lead-charge-protect-us">reported</a> Fox News, quoting the president's comments on social media.
"It is my great honor to announce Sara Carter as our next Director of the Office of National Drug Control Policy (ONDCP). Sara is an Award Winning Journalist, who has been on the front lines of this International Fight for decades," Trump <a href="https://truthsocial.com/@realDonaldTrump/posts/114241662387997605">wrote</a> on Truth Social. "From Afghanistan to our Border, Sarah's relentless pursuit of Justice, especially in tackling the Fentanyl and Opioid Crisis, has exposed terrorists, drug lords, and sex traffickers. As our next Drug Czar, Sara will lead the charge to protect our Nation, and save our children from the scourge of drugs.
Like most of Trump&#8217;s appointees and cabinet members, Carter is a former Fox News contributor who has called for stronger border policies.
What sets her apart is that Carter has called medical marijuana a "fantastic" treatment for seriously ill people and apparently, she has no problem with legalizing cannabis. But, it's not her cup of tea.
"I don't have any problem if it's legalized and it's monitored," she said in her podcast The Sara Carter Show, <a href="https://www.marijuanamoment.net/trumps-new-white-house-drug-czar-called-medical-marijuana-a-fantastic-treatment-for-cancer-patients/">reported</a> Marijuana Moment. "I mean, I may have my own issues of how I feel about that, but I do believe that cannabis for medicinal purposes and medical reasons is a fantastic way of handling — especially for people with cancer and other illnesses, you know — of handling the illness and the side effects of the medication and those illnesses. So I'm not saying we've gotta make it illegal."
During his presidential campaign, Trump himself <a href="https://www.benzinga.com/markets/cannabis/24/08/40666944/donald-trump-supports-cannabis-legalization-in-florida-game-changer-and-huge-blow-to-ron-desanti" target="_blank" rel="noopener">made overtures</a> to that same idea. However, he has since barely mentioned the idea of federally legalizing cannabis and welcoming the $30 billion industry into the fold.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/03/44543635/trump-links-cannabis-decriminalization-to-disorder-in-dc-establishes-law-enforcement-task-force">Trump Links Cannabis Decriminalization To &#8216;Disorder&#8217; In DC, Establishes Law Enforcement Task Force</a></li>
</ul>

Cannabis

Government

Politics

Legal

Trump's New Drug Czar: Cannabis Is 'Fantastic' For People With Serious Illnesses

President Donald Trump is preparing to announce his most expansive tariff plan to date, set to take effect on April 2 — a date he has dubbed &#8220;Liberation Day.&#8221; While specifics remain unclear, he has said the plan will impose &#8220;reciprocal tariffs&#8221; on countries deemed to have unfair trade barriers against U.S. goods, with some nations set to face steeper <a href="https://www.benzinga.com/trading-ideas/25/03/44566164/exclusive-could-trumps-liberation-day-reciprocal-tariffs-crash-the-stock-market-48-say-this">consequences than others. </a>
What To Know: Treasury Secretary Scott Bessent has hinted at targeting a subset of nations he referred to as the &#8220;Dirty 15&#8221; in a Fox Business interview on March 18. Bessent described the "Dirty 15" as the 15% of nations that account for the bulk of U.S. trading volume and impose hefty tariffs and other barriers on U.S. goods.&nbsp;
Read Next:<a href="https://www.benzinga.com/government/regulations/25/03/44517885/trump-slaps-25-tariffs-on-autos-what-it-means-for-your-next-car-purchase"> Trump Slaps 25% Tariffs On Autos: What It Means For Your Next Car Purchase</a>&nbsp;
National Economic Council Director Kevin Hassett similarly cited 10 to 15 countries responsible for the U.S.'s $1 trillion trade deficit, though neither official named specific nations.
Dirty 15: A CNBC<a href="https://www.cnbc.com/2025/03/31/trump-tariffs-dirty-15-reciprocal-retaliation.html"> report pointed</a> to 2024 data from the Department of Commerce that identified China, the EU, Mexico, Vietnam, Germany, Taiwan, Japan, South Korea, Canada, India, Thailand, Italy, Switzerland, Malaysia, Indonesia, France, Austria and Sweden.
A separate U.S. Trade representative notice flagged 21 countries in which it is "particularly interested" as part of a review of <a href="https://ustr.gov/about-us/policy-offices/press-office/press-releases/2025/february/ustr-seeks-comment-public-unfair-and-non-reciprocal-foreign-trade-practices-0">unfair trade practices</a>. The countries listed were: Argentina, Australia, Brazil, Canada, China, the EU, India, Indonesia, Japan, Korea, Malaysia, Mexico, Russia, Saudi Arabia, South Africa, Switzerland, Taiwan, Thailand, Turkey, the U.K. and Vietnam.
It remains unclear exactly which countries will be targeted in Wednesday's tariff announcements. CNBC said the White House did not respond to its request for clarification on the forthcoming tariffs or the Dirty 15.
Trump on Sunday dismissed the idea of limiting tariffs to a select group, stating the measures would &#8220;start with all countries&#8221; and lack a &#8220;cutoff.&#8221; Trump's comments contradicted earlier suggestions of a narrower focus and fueled market volatility, with global stocks sliding ahead of the announcement.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), tracking the S&amp;P 500, shed 5.86% over the past month and the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), tracking the Nasdaq 100 index, dropped 7.72% in March amid the political and economic uncertainty.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/03/44537429/cathie-wood-doubles-down-on-2600-tesla-stock-price-prediction">Cathie Wood Doubles Down On $2,600 Tesla Stock Price Prediction</a></li>
</ul>
Photo: Shutterstock

Regulations

Broad U.S. Equity ETFs

Global

Economics

ETFs

Trump To Target 'Dirty 15' Countries With Tariffs: Which Countries Could Be Included?

Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) has outperformed the market over the past 5 years by 12.12% on an annualized basis producing an average annual return of 29.77%. Currently, Apple has a market capitalization of $3.32 trillion. 
Buying $100 In AAPL: If an investor had bought $100 of AAPL stock 5 years ago, it would be worth $362.76 today based on a price of $221.28 for AAPL at the time of writing.
<h3>Apple's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743462907_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

Here's How Much $100 Invested In Apple 5 Years Ago Would Be Worth Today

Live Nation Entertainment Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) shares turned lower after the market close on Monday following reports that President Donald Trump is preparing to sign an executive order to <a href="https://www.benzinga.com/news/25/03/44571188/president-trump-plans-to-sign-executive-order-aimed-at-protecting-fans-from-exploitative-ticket-scal">stop ticket scalping</a>.
What Happened: CNBC reported Monday on &#8220;Closing Bell: Overtime&#8221; that Trump is set to sign an executive order targeting price gouging in the live entertainment industry. 
The Trump administration will reportedly direct the Federal Trade Commission (FTC) to work with the attorney general to enforce competition laws within the industry. The executive order is expected to direct the FTC to ensure price transparency and to take enforcement action to prevent unfair and deceptive competitive conduct. 
The Trump administration will also ask the Treasury Department to get involved by working with the attorney general to make sure ticket scalpers are abiding by the law.
A report on the initial adjustments is due within 180 days. At that point, the government will determine if any additional legislation is needed. 
President Trump is expected to sign the executive order in the Oval Office at 5:30 p.m. ET. CNBC reported American musician Kid Rock will be in attendance at the signing.
Live Nation is a live entertainment company comprised of Ticketmaster, Live Nation Concerts and Live Nation Media &amp; Sponsorship.
LYV Price Action:<a href="http://benzinga.com/quote/lyv"> Live Nation shares</a> were down 1.98% after hours, trading at $127.99 at the time of publication Monday, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44570070/tariffs-inflation-and-tumbling-markets-these-5-etfs-thrived-amid-the-chaos-last-week">Tariffs, Inflation And Tumbling Markets: These 5 ETFs Thrived Amid Last Week&#8217;s Chaos</a></li>
</ul>
Photo: Shutterstock.

Entertainment

After-Hours Center

Movers

Live Nation Shares Slide As Trump Moves To Sign Executive Order On Ticket Scalping

Agnico Eagle Mines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEM#NYSE">AEM</a>) has outperformed the market over the past 20 years by 2.63% on an annualized basis producing an average annual return of 10.67%. Currently, Agnico Eagle Mines has a market capitalization of $54.57 billion. 
Buying $1000 In AEM: If an investor had bought $1000 of AEM stock 20 years ago, it would be worth $7,623.77 today based on a price of $108.46 for AEM at the time of writing.
<h3>Agnico Eagle Mines's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743462021_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Agnico Eagle Mines Stock In The Last 20 Years

Houlihan Lokey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLI#NYSE">HLI</a>) has outperformed the market over the past 5 years by 5.06% on an annualized basis producing an average annual return of 22.7%. Currently, Houlihan Lokey has a market capitalization of $11.33 billion. 
Buying $1000 In HLI: If an investor had bought $1000 of HLI stock 5 years ago, it would be worth $2,892.19 today based on a price of $161.50 for HLI at the time of writing.
<h3>Houlihan Lokey's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743461108_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Since its release on Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) on March 13, "Adolescence" has been one of the most-watched series on the streaming platform, adding to the potential strong lineup <a href="https://www.benzinga.com/25/02/43700767/netflix-stock-attractive-at-all-time-highs-for-analyst-virtuous-circle-of-strong-subscriber-growth-more-revenue-and-growing-profit">of 2025 content.</a>
Billionaire Elon Musk shared a theory about the series, which has the show's co-writer clapping back at his allegations.
What Happened: Netflix<a href="https://www.benzinga.com/news/earnings/25/01/43114866/netflix-q4-earnings-record-subscribers-nfl-squid-game-push-past-highest-expectations"> ended the fourth quarter</a> with 301.63 million paid subscribers. The streaming giant could add to that figure throughout 2025 with many highly anticipated series coming back.
Adding to the 2025 early hype is "Adolescence."
While the series has drawn plenty of support, one social media user accused the series of "anti-white propaganda."
"Netflix has a show called Adolescence that's about a British knife killer who stabbed a girl to death on a bus and it's based on real-life cases such as the Southport murderer. So guess what. They race swapped the actual killer from a black man/migrant to a white boy and the story has it so he was radicalized online by the red pill movement. Just the absolute state of anti-white propaganda," journalist Ian Miles Cheong <a href="https://x.com/elonmusk/status/1902586606575313345">tweeted</a>.
The tweet drew the attention of Musk, who replied, "Wow."
Another X user was quick to point out some false items in Cheong's tweet, including that the series was written and filming began before Southport happened.
Jack Thorne, who co-wrote "Adolescence," is now speaking out to clear the air. Thorne said on a podcast that "nothing could be further from the truth" when discussing the race-swapping allegations, as reported by <a href="https://variety.com/2025/tv/global/adolescence-writer-rejects-race-swap-theory-elon-musk-1236352337/">Variety</a>.
"There is no part of this that's based on a true story, not one single part," Thorne said.
The series co-writer said having a white boy in the series isn't about making a point about race.
"We're not making a point about race with this. We are making a point about masculinity. We're trying to get inside a problem. We're not saying this is one thing or another, we're saying that this is about boys."
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul>
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
 Why It's Important: The series drew 24.3 million views in its first week on Netflix and an additional 42 million views in its second week, ranking first among English-language shows each week.
On <a href="https://www.imdb.com/title/tt31806037/">IMDb</a>, the series ranks number one in popularity and has an 8.3 rating out of 10. The series also has top <a href="https://www.rottentomatoes.com/tv/adolescence">ratings </a>on Rotten Tomatoes, with a critic rating of 99% and an audience score of 73%.
Musk's amplification of the anti-white propaganda post could keep some people from watching the series, which may be bad for Netflix.
The response from the show's co-writer is another example of how dangerous posts on social media can be in getting others to believe something just because another person said it was true.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/05/38776258/tesla-ceo-elon-musk-draws-parallel-between-netflixs-decision-to-focus-on-streaming-over-renting-dvds">Tesla CEO Elon Musk Draws Parallel Between Netflix&#8217;s Decision To Focus On Streaming Over Renting DVDs To EV Maker Doubling Down On Vehicle Autonomy</a></li>
</ul>
Photo: Shutterstock

NFLX

Elon Musk Attacks Netflix Hit Series, Shares 'Anti-White Propaganda' Allegation: Here's How The Show's Writer Claps Back

Advanced Energy Indus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEIS#NASDAQ">AEIS</a>) has outperformed the market over the past 15 years by 1.75% on an annualized basis producing an average annual return of 12.62%. Currently, Advanced Energy Indus has a market capitalization of $3.61 billion. 
Buying $100 In AEIS: If an investor had bought $100 of AEIS stock 15 years ago, it would be worth $593.83 today based on a price of $95.31 for AEIS at the time of writing.
<h3>Advanced Energy Indus's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743460214_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEIS

Here's How Much $100 Invested In Advanced Energy Indus 15 Years Ago Would Be Worth Today

If your last name is Buffett, <a href="https://www.benzinga.com/personal-finance/25/03/44482365/warren-buffetts-son-wasnt-raised-like-a-billionaires-kid-he-mowed-lawns-and-cleaned-gutters-because-there-are-jerks-with-money-and-jerks-without">people assume you're rich</a>. Not just "doing well" rich. Private jet, personal sushi chef, champagne-for-breakfast rich. But according to Howard Buffett—Warren Buffett's son—you'd be wrong. Very wrong.
In a <a href="https://fortune.com/2012/11/21/the-children-of-the-rich-and-famous/">1990 Fortune interview</a>, Howard explained people often attempt to use him just to get something from his dad. "When I get back to my office this afternoon, there will be nine messages," he said. "Eight of them will be from people wanting something from my dad." That was decades ago. Before viral GoFundMes, LinkedIn pitches, and inboxes flooded with crypto ideas. Howard was already living in the shadow of the world's most famous value investor, fielding daily requests just for having the audacity to share a surname.
Don't Miss:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
And it wasn't just inbox clutter.
"One night at a restaurant," he recalled, "I pulled out my checkbook to pay the bill, and some guy says, ‘Gee, I wish I had that checkbook!' I didn't have the patience to tell him, ‘No, buddy, you really don't.'"
<h2 class="wp-block-heading">A Billionaire Dad… But Rent's Still Due</h2>
While Warren Buffett built a financial empire out of Omaha, his kids didn't grow up with butlers or gated mansions. In fact, Howard became a farmer—and a grounded one. At one point, he was paying his own father rent for the land. Because, yes, even if your dad is worth over $100 billion, Warren still wants you to understand the value of a dollar and in this case, the value of a lease agreement.&nbsp;
The Buffett kids—Howard, Susie, and Peter—have long echoed the same message: their dad's money isn't their money.
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a>
<h2 class="wp-block-heading">Then Came the $600 Million Gift —Sort Of</h2>
Now, to be fair, Warren isn't stingy. He's just strategic. In 2012, as <a href="https://www.nbcnews.com/businessmain/warren-buffett-his-birthday-gives-kids-600m-972645">NBC News reported</a>, he rang in his 82nd birthday by giving each of his three kids a gift… about $600 million worth of Berkshire Hathaway stock. But there's a twist—this wasn't for shopping sprees or yachts. It was for their charitable foundations.
That move brought each child's philanthropic firepower to a billion-dollar level, while still aligning with their dad's core belief: "You should leave your children enough so they can do anything, but not so much that they can do nothing."
Translation? You're getting capital—but not carte blanche.
<h2 class="wp-block-heading">Buffett's Inbox Problem Became Doris's Mission</h2>
Of course, when word gets out that you're charitable—your mailbox turns into a wish list. When Warren Buffett pledged in 2006 to give away most of his wealth, <a href="https://www.politico.com/story/2014/05/warren-buffett-doris-sister-sunshine-lady-foundation-107104">Politico</a> reported he was swamped with letters asking for help. Instead of ignoring them, he called in reinforcement: his older sister Doris.
Doris set up the Letters Foundation, a kind of philanthropic triage unit where real people with real problems—often just victims of bad luck—could get help. According to Warren, Doris and her all-women team "believe a lot of people got short straws in life, and she wants to help them." And unlike most billionaire philanthropy, these weren't high-profile causes or gala-funded grants. These were everyday people in crisis, and Doris read their stories one by one.
See Also: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
<h2 class="wp-block-heading">So…Is Howard Rich Now?</h2>
Back in 1990, Howard insisted he wasn't rich. But since then, he's been entrusted with a charitable foundation sitting on hundreds of millions of dollars in assets—and growing. That doesn't make him personally wealthy in the traditional sense, but it does mean he's rich in influence, especially when it comes to causes he cares about—like food security and conservation.
<h2 class="wp-block-heading">In Buffett World, Legacy Over Luxury</h2>
Warren Buffett's legacy isn't just his investment track record—it's how deliberately <a href="https://www.benzinga.com/startups/24/11/41866296/with-warren-buffett-donating-99-of-his-fortune-whats-left-for-his-three-children-well-its-complicated">unspoiled he's kept his children</a>.&nbsp;
And if you're wondering how Warren himself defines rich? According to Alice Schroeder's biography of Buffett, "The Snowball: Warren Buffett and the Business of Life," he told student as the University of Georgia in 2001, "If you get to my age in life and nobody thinks well of you, I don't care how big your bank account is, your life is a disaster."
Read Next:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>

Personal Finance

Billionaire Warren Buffett's Son Says Everyone Assumes He's Rich — 8 Out of 10 Messages a Day Are Just 'People Wanting Something From My Dad'

Earnings

BATL

Battalion Oil Q4 Adj EPS $(0.04) Up From $(1.02) YoY

Detroit automakers are attempting to reassure their employees as they work to mitigate challenges posed by President Donald Trump&#8217;s sweeping 25% tariffs on imported vehicles and auto parts set to go<a href="https://www.benzinga.com/25/03/44560524/auto-stocks-skid-after-trump-shrugs-off-higher-prices-should-you-buy-the-dip"> into effect on Thursday.&nbsp;</a>
What To Know: The Detroit Free Press said it <a href="https://www.freep.com/story/money/cars/ford/2025/03/30/gm-ford-leaders-assure-employees-companies-future-amid-auto-tariffs/82721842007/">obtained</a> internal memos dated March 27 from both General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) and Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>).
Ford CEO Jim Farley told employees in the memo that the company is still examining <a href="https://www.benzinga.com/government/regulations/25/03/44517885/trump-slaps-25-tariffs-on-autos-what-it-means-for-your-next-car-purchase">potential impacts </a>from the tariffs, which it expects to be &#8220;likely to be significant." 
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/03/44537429/cathie-wood-doubles-down-on-2600-tesla-stock-price-prediction">Cathie Wood Doubles Down On $2,600 Tesla Stock Price Prediction</a>
&#8220;While Ford supports the president's vision of building a stronger auto industry and manufacturing base in the United States, the situation is dynamic and the impacts of the tariffs are likely to be significant across our industry — affecting automakers, suppliers, dealers and customers,&#8221; Farley wrote. 
He noted nearly 80% of the vehicles Ford sells in the states are made in the U.S. but, &#8220;this does not mean Ford is immune to the impact of tariffs, which could be meaningful.&#8221;
&#8220;I assure you that our Ford team has been and will continue to engage closely with the Trump administration as well as policymakers in the U.S., Canada, Mexico and other markets to help shape these critical trade and policy issues,&#8221; Farley added. 
The Detroit Free Press also reported that it obtained an unsigned internal memo from General Motors which noted the tariffs will have an impact on the company's manufacturing operations and supply chain, though it did not give exact figures or estimates. 
The memo did say GM leadership is planning to keep the company &#8220;nimble based on any tariffs announced by the U.S. administration,&#8221; and the company supports a strong U.S.-based auto industry. 
It also encouraged employees to focus on their work and on managing costs.&nbsp;
&#8220;We are in a strong position to navigate this dynamic situation and will continue to deliver for our customers, employees, and communities. Each of us can contribute by staying focused and delivering on plans for this year, maintaining a disciplined approach and managing discretionary costs,&#8221; the GM memo reads.&nbsp;
What Else: President Trump on Saturday expressed <a href="https://www.benzinga.com/markets/25/03/44552465/trump-unfazed-by-potential-auto-price-hikes-amid-new-tariffs-i-couldnt-care-less">his anticipation </a>for price increases in response to the tariffs on auto imports and reaffirmed his decision to raise tariffs in an effort to boost American manufacturing.
"I couldn't care less if they raise prices, because people are going to start buying American-made cars," Trump stated in an interview <a href="https://www.nbcnews.com/politics/donald-trump/trump-says-couldnt-care-less-automakers-raise-prices-tariffs-rcna198731">with</a> NBC News.&nbsp;
GM, F Price Action: General Motors shares ended Monday's session 0.75% higher at $47.03 and Ford shares closed 3.19% higher at $10.03, according to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>. 
Read Next:<a href="https://www.benzinga.com/general/social-media/25/03/44563161/trump-says-tiktok-has-a-lot-of-potential-buyers-deal-to-come-before-saturday-deadline">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/03/44563161/trump-says-tiktok-has-a-lot-of-potential-buyers-deal-to-come-before-saturday-deadline">Trump Says TikTok Has &#8216;A Lot Of Potential Buyers,&#8217; Deal To Come Before Saturday Deadline</a></li>
</ul>
Photo: Shutterstock

Management

Ford, GM Executives Address Trump Tariffs In Internal Memos Aimed To Reassure Employees: Report

Guidance

Babcock & Wilcox Expects Full Year 2025 Adjusted EBITDA Of $70M - $85M

Babcock & Wilcox Reveals Discussions Regarding Refinancing Of Debt With Key Bondholders In Addition To Other Potential Asset Sales

TPCS

TechPrecision  Appoints Phillip E. Podgorski As Its New CFO, Effective Today

ELLO

Ellomay Capital Q4 Revenues $9.033M

Throughout the last three months, 12 analysts have evaluated Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>), offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $26.5, a high estimate of $33.00, and a low estimate of $22.00. This upward trend is evident, with the current average reflecting a 17.05% increase from the previous average price target of $22.64.
<img src="https://www.benzinga.com/files/images/story/2025/1743458491_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A clear picture of Unity Software's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Uerkwitz</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$24.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Andrew Boone</td>
<td>Citizens Capital Markets</td>
<td>Announces</td>
<td>Market Outperform</td>
<td>$30.00</td>
<td>-</td>
</tr>
<tr>
<td>Tim Nollen</td>
<td>Macquarie</td>
<td>Raises</td>
<td>Neutral</td>
<td>$24.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Alec Brondolo</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$22.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Matthew Cost</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$32.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Alec Brondolo</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$27.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Andrew Uerkwitz</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$28.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$33.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Ross Sandler</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$26.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Chris Kuntarich</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$23.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Matthew Cost</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$26.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Andrew Uerkwitz</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$23.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Unity Software. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Unity Software compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Unity Software's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Unity Software's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/U/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Unity Software analyst ratings.</a>
<h2>Discovering Unity Software: A Closer Look</h2>
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. The products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
<h3>Breaking Down Unity Software's Financial Performance</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Unity Software's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -24.98%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Unity Software's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -26.85%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -3.85%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Unity Software's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -1.82%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a high debt-to-equity ratio of 0.7, Unity Software faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

The Analyst Verdict: Unity Software In The Eyes Of 12 Experts

Analysts' ratings for Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) over the last quarter vary from bullish to bearish, as provided by 27 analysts.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">15</td>
<td align="right">9</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">6</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $338.44, with a high estimate of $500.00 and a low estimate of $280.00. Witnessing a positive shift, the current average has risen by 5.09% from the previous average price target of $322.04.
<img src="https://www.benzinga.com/files/images/story/2025/1743458484_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Alnylam Pharmaceuticals. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Harrison</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$342.00</td>
<td>$338.00</td>
</tr>
<tr>
<td>Joshua Smith</td>
<td>Redburn Atlantic</td>
<td>Announces</td>
<td>Buy</td>
<td>$353.00</td>
<td>-</td>
</tr>
<tr>
<td>Paul Matteis</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$345.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Jessica Fye</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$328.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>David Lebovitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$351.00</td>
<td>$338.00</td>
</tr>
<tr>
<td>Whitney Ijem</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$390.00</td>
<td>$385.00</td>
</tr>
<tr>
<td>Luca Issi</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$330.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Greg Harrison</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$338.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Tiago Fauth</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$287.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Tazeen Ahmad</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$325.00</td>
<td>$302.00</td>
</tr>
<tr>
<td>Keay Nakae</td>
<td>Chardan Capital</td>
<td>Maintains</td>
<td>Buy</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$320.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Jessica Fye</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$280.00</td>
<td>$272.00</td>
</tr>
<tr>
<td>Luca Issi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$310.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Keay Nakae</td>
<td>Chardan Capital</td>
<td>Maintains</td>
<td>Buy</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$320.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$500.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$500.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Whitney Ijem</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$385.00</td>
<td>$384.00</td>
</tr>
<tr>
<td>Greg Harrison</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$300.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Michael Ulz</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$284.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$320.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Luca Issi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Luca Issi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Patrick Trucchio</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$400.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Joseph Stringer</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$320.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>William Pickering</td>
<td>Bernstein</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$310.00</td>
<td>$314.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Alnylam Pharmaceuticals. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Alnylam Pharmaceuticals compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Alnylam Pharmaceuticals's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Alnylam Pharmaceuticals's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ALNY/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Alnylam Pharmaceuticals analyst ratings.</a>
<h2>About Alnylam Pharmaceuticals</h2>
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
<h3>Alnylam Pharmaceuticals: Delving into Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Alnylam Pharmaceuticals's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 34.9%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -14.12%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -168.47%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Alnylam Pharmaceuticals's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -1.98%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Alnylam Pharmaceuticals's debt-to-equity ratio stands notably higher than the industry average, reaching 19.32. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>Analyst Ratings: Simplified</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALNY

27 Analysts Assess Alnylam Pharmaceuticals: What You Need To Know

Press Releases

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Summit Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results & Operational Progress Call on February 24, 2025

Summit Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs)

Comments

Summit Therapeutics

Actualités

Dernières nouvelles pour Summit Therapeutics (NASDAQ:SMMT) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL